Investment in innovative pharmaceutical industry solutions including:
* Technologies to improve patient compliance and medication adherence
* Solutions to authenticate dosage forms and reduce impact of diversion and
counterfeiting of medications
* Transformational technologies disrupting conventional doasge delivery pathways
* Smart technologies for digital and personalized medicines
* Breakthrough technologies and advanced manufacturing processes
* Other intelligent solutions to address unmet needs in pharmaceutical technology
or supply chains
Note: We are currently not investing in active pharmaceutical ingredient (API) or therapeutic molecule development
Company Details
- Employees
- 2
- Founded
- 2019
- Address
- 275 Ruth Road, Harleysville,pa 19438,united States
- Industry
- Venture Capital And Private Equity Principals
- NAICS
-
Miscellaneous Intermediation
- Website
- http://www.colorcon.com/ventures
- Keywords
- Patient Compliance, Medication Adherence, Dosage Authentication, Digital Medicine, Personalized Medicine, Advanced Manufacturing, Supply Chain, Pharmaceutical Innovation, Pharmaceutical Technology.
- HQ
- Harleysville, PA
Colorcon Ventures Questions
Colorcon Ventures's website is http://www.colorcon.com/ventures
Colorcon Ventures's LinkedIn profile is https://www.linkedin.com/company/colorcon-ventures
Colorcon Ventures has
2 employees.
View email and phone details for 2
employees at Colorcon Ventures.
Colorcon Ventures's industry is
Venture Capital and Private Equity Principals
Colorcon Ventures's top competitors are
Mend™,
Intersect Vc,
Synchromedical - A Brand Of Tyber Medical,
Cerberus Capital Management,
J&j Innovative Medicine Korea,
Colorcon®,
Vedanta Biosciences, Inc.,
Syntis Bio,
Cerity Partners Ventures,
Colorcon Asia Private Limited.
Colorcon Ventures's categories are Venture Capital and Private Equity Principals
Colorcon Ventures's founding year is 2019
